Xu, W., Li, Q. Progress in the development of aminopeptidase N (APN/CD13) inhibitors. Curr. Med. Chem. Anticancer Agents 2005, 5(3): 281-301.
Hits:
|
Pre One:Li, Q., Xu, W. Novel anticancer targets and drug discovery in post genomic age. Curr. Med. Chem. Anticancer Agents 2005, 5(1): 53-63.
Next One:Li, Q., Wu, J., Zheng, H., Liu, K., Guo, T.L., Liu, Y., Eblen, S.T., Grant, S., Zhang, S. Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine -2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways. Bioorg. Med. Chem. Lett. 2010, 20(15): 4526-4530.
